Correlation Between Stoke Therapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Fate Therapeutics, you can compare the effects of market volatilities on Stoke Therapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Fate Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Fate Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Fate is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Fate Therapeutics
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Fate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Stoke Therapeutics is 2.26 times less risky than Fate Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Fate Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 243.00 in Fate Therapeutics on September 2, 2024 and sell it today you would earn a total of 74.00 from holding Fate Therapeutics or generate 30.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Fate Therapeutics
Performance |
| Timeline |
| Stoke Therapeutics |
| Fate Therapeutics |
Stoke Therapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Fate Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Stoke Therapeutics vs. Tff Pharmaceuticals | Stoke Therapeutics vs. Eliem Therapeutics | Stoke Therapeutics vs. Inhibrx | Stoke Therapeutics vs. Enliven Therapeutics |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |